CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Conversion | +2,333,955 | 2,333,955 | ||
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Conversion | +543,101 | 2,877,056 | ||
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Purchase | +164,963 | $13.50 | $2.2M | 3,042,019 |
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Conversion · Series B Preferred Stock | −2,333,955 | 0 | ||
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Conversion · Series C Preferred Stock | −543,101 | 0 | ||
| 2014-11-06 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +134,973 | 134,973 | ||
| 2014-11-06 | LAWLIS V BRYAN Director | Grant or award · Stock Option (Right to Buy) | +14,997 | 14,997 | ||
| 2014-11-06 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +14,997 | 14,997 |
Page 39 of 39 · 768 trades